AAD 2026Abstract 72091
SPECTREM: Guselkumab Skin Clearance and Patient-Reported Outcome Results Across Skin and Joint Symptoms Through Week 48 in Low Body Surface Area, Moderate Plaque Psoriasis With at Least One Moderate High-Impact Site Involved
Gold LS, Papp KA, Langley RG, Strober B, Armstrong AW, Bissonnette R, Gottlieb AB, Krueger JG, Merola JF, Alkousakis T, Lebwohl MG
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Psoriasis
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1635 · Not in PubMed: details from Crossref